Jerry Peter

Chief Executive Officer & Board Director at Xequel Bio - Fort Worth, Texas, United States

Jerry Peter's Colleagues at Xequel Bio
Meghan Bowler

Translational Scientist

Contact Meghan Bowler

Susanne Haugebak

Director Clinical Operations

Contact Susanne Haugebak

Carissa James

Director of Research and Development

Contact Carissa James

Linda Davis

Sr. Director, Administration & HR

Contact Linda Davis

View All Jerry Peter's Colleagues
Jerry Peter's Contact Details
HQ
+1 843-860-8372
Location
Fort Worth,Texas,United States
Company
Xequel Bio
Jerry Peter's Company Details
Xequel Bio logo, Xequel Bio contact details

Xequel Bio

Fort Worth, Texas, United States • 10 Employees
Research

Xequel Bio, Inc. is a clinical stage biopharmaceutical company advancing its proprietary aCT1 (alpha-Connexin carboxyl-Terminal 1 peptide) technology platform to develop drugs that will enable physicians to better manage a variety of indications involving inflammation and the body's response to injury.aCT1 is a patented new chemical entity currently in development for multiple indications. The Company's lead clinical programs include Granexin® gel in dermatology and iNexinTM ophthalmic solution in ophthalmology. The Company also has ongoing preclinical research in pulmonology.

Details about Xequel Bio
Frequently Asked Questions about Jerry Peter
Jerry Peter currently works for Xequel Bio.
Jerry Peter's role at Xequel Bio is Chief Executive Officer & Board Director.
Jerry Peter's email address is ***@xequel.com. To view Jerry Peter's full email address, please signup to ConnectPlex.
Jerry Peter works in the Research industry.
Jerry Peter's colleagues at Xequel Bio are Meghan Bowler, Susanne Haugebak, Carissa James, Linda Davis, Irina Adamova, Kayla Wilson and others.
Jerry Peter's phone number is +1 843-860-8372
See more information about Jerry Peter